Bosulif Tablet, Film Coated
Product Images NDC 63539-193

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bosulif (NDC 63539-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bosulif 01)

Chemical structure diagram of Bosutinib, the active ingredient in BOSULIF 400 mg tablets by U.S. Pharmaceuticals. The structure shows the molecular configuration including chlorine, methoxy, cyano groups, and a hydrated form with H2O.*

FDA Label Image

Logo (Bosulif 02)

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Bosulif (bosutinib) tablets, 100 mg strength, by U.S. Pharmaceuticals and Pfizer. The label indicates 120 tablets per container with instructions including storage conditions and that it is for oncology use only. It is marked as a professional sample and not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.